We're Keeping An Eye On Editas Medicine's (NASDAQ:EDIT) Cash Burn Rate [Yahoo! Finance]
Editas Medicine, Inc. (EDIT)
Last editas medicine, inc. earnings: 2/26 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.editasmedicine.com
Company Research
Source: Yahoo! Finance
lose money for years before finding success with a new treatment or mineral discovery. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com? So, the natural question for Editas Medicine NASDAQ:EDIT ) shareholders is whether they should be concerned by its rate of cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. View our latest analysis for Editas Medicine Does Editas Medicine Have A Long Cash Runway? A company's cash runway is calculated by dividing its cash hoard by its cash burn. As at June 2024, Editas Medicine had cash of US$279m and no debt. In the last year, its cash burn was US$172m. That means it had a cash runway of around 20 months as of June 2024. That's not too bad, but it's fair
Show less
Read more
Impact Snapshot
Event Time:
EDIT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EDIT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EDIT alerts
High impacting Editas Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
EDIT
News
- Editas Medicine, Inc. (NASDAQ: EDIT) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock.MarketBeat
- Editas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]Yahoo! Finance
- Editas Medicine, Inc. (EDIT) Presents at Wells Fargo 2024 Healthcare Conference (Transcript) [Seeking Alpha]Seeking Alpha
- Editas Medicine, Inc. (EDIT) Presents at Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) [Seeking Alpha]Seeking Alpha
- Editas Medicine to Participate in Upcoming Investor ConferencesGlobeNewswire
EDIT
Earnings
- 8/7/24 - Miss
EDIT
Sec Filings
- 9/6/24 - Form 4
- 9/6/24 - Form 4
- 8/29/24 - Form 144
- EDIT's page on the SEC website